Background: To correlate the imaging and pathological features and to discuss therapeutic modalities and the prognosis of malignant lymphoma originating in the parotid gland, which is relatively rare. Methods: The subjects were five patients with malignant lymphoma originating in the parotid gland. Three andtwopatients were stage I andstage II,respectively. CTexamination wasapplied to all, whereas onlyonecase was examined by MRI. All weretreated with radiotherapy following surgery or chemotherapy. Three patients underwent combination chemotherapy, such as with MACOP-P or VEPA, following surgery. Results: Although malignant lymphoma originating inthe parotid gland is histologically described as low-grade non-Hodgkin's lymphoma, twoandoneof the cases were classified as intermediate and high grade inthe present series, respectively. These three exhibited a tendency for infiltration intothe adjacent tissue andtumorinhomogeneity intheimaging findings, suggesting a correlation with histologically intermediate or high-grade non-Hodgkin's lymphoma. It was successfully controlled by radiotherapy, with dosages ranging from 40 to 44 Gy. Thepatients werefollowed for 2-8 years. No relapse wasfound in the three patients with stage I. However, bothstage II patients had relapses andwere subjected to additional radiotherapy combined withchemotherapy. Since then, no tumor relapse has been noted at either this or othersites. Conclusions: Malignant lymphoma including intermediate or highgrade originating inthe parotid gland indicated satisfactory prognosis following radiotherapy and chemotherapy.
INTRODUCTION
It has been reported that primary tumors of the parotid gland show no characteristic features in diagnostic imaging, reflecting none of their histological findings (1) . Therefore, it is difficult to differentiate benign conditions from malignant tumors and most patients are subjected to surgical procedures before a definitive diagnosis has been made. The head and neck region is the most common site where malignant lymphomas occur, but malignant lymphoma of the parotid gland is relatively rare (2) . As stated before, the imaging features are non-contributory to a diagnosis and the majority of patients are surgically treated. However, radiotherapy and chemotherapy are also effective, often with a favorable prognosis, so it is desirable to differentiate malignant lymphoma of the parotid gland from other tumors prior to surgery. We recently encountered five cases of malignant lymphoma of the parotid gland. The purpose of this paper is to present the CT and MRI fmdings, therapeutic modalities and the prognosis of malignant lymphoma of the parotid gland.
MATERIALS AND METHODS
The subjects were five patients with malignant lymphoma originating in the parotid gland. They had been treated at the Department of Radiology, Sapporo Medical University, between September 1985 and January 1995. The patients (one male and four females) ranged from 44 to 74 years of age (mean 55.4 years). No patients suffered complication of facial nerve palsy or Sjogren's syndrome. Patients were staged according to the Ann Arbor criteria. All specimens were stained with hematoxylineosin and monoclonal antibodies (CD20, CD45RO) and classi-fied according to the working formulation (WF). The characteristics seen at CT and MRI imaging of the parotid gland, such as tumor size, tumor margins, signal intensity, tumor homogeneity and tumor infiltration into adjacent tissues, correlated with malignant lymphoma. The CT examination was applied to all, whereas only one case was examined by MRI. As a therapeutic policy, all were first subjected to surgical procedure, which included total parotidectomy for one, superficial parotidectomy for two and biopsy for two cases. Of the two patients who underwent superficial parotidectomy, the procedure was combined with cervical lymph node dissection in one. Three and two patients were stage I and stage II, respectively. Bilateral cervical lymph node involvement was noted in both stage II patients. In three cases the surgical procedure was followed by chemotherapy. All were treated with radiotherapy following surgery or Table 1 . Patients' characteristics chemotherapy. The radiation dosage applied to the tumor ranged from 40 to 44 Gy.
RESULTS

PATHOLOGICAL FINDINGS
According to the WF classification, two patients had diffuse large cells as intermediate grade, one had diffuse small cleaved immunoblastic type cells as high grade and one had follicular mixed cell type as low grade. The remaining patient had MALT lymphoma (Table 1) . When classified by surface markers, all five cases belonged to the B-cell type. When the primary site was classified by the location, the tumor was situated in the superficial lobe in three cases, deep lobe in one case and both in one case. 
IMAGING FINDINGS
In the imaging examination, emphasis was placed on the manner of infiltration into the adjacent tissue and the internal homogeneity of the tumor. Cases 1 and 4 exhibited homogeneity with absence of infiltration. The tumor margin was well defined in case 1 and case 4 showed an ill-defined tumor margin with multiple projections ( Table 2 ). The tumors had rapidly increased in size within 2 months in cases 2, 3 and 5. All exhibited infiltration into the adjacent vasculature, muscles and subcutaneous tissue and necrosis or cystic changes of the internal structures, suspected to be retention cysts (Figs I and 2 ).
TREATMENT
All subjects underwent surgical procedure. According to the specific locations of the foci, superficial parotidectomy (two cases) or total parotidectomy (one case) was done. More recently, biopsies have been performed in two cases for intraoperative rapid pathological diagnosis (the frozen section) when malignant lymphoma was suspected. Cases 2, 3 and 5 underwent combination chemotherapy, such as with MACOp·P or VEPA, following surgery. For radiotherapy, cobalt y-irradiation was employed for all subjects. Cases 3 and 4 were irradiated on the parotid gland where the lesion was located and on the ipsilateral neck through the lateral portal. Case 1 was irradiated on the parotid gland, oropharynx and whole neck including through the parallel opposed lateral portals and antero-posterior portals. Cases 2 and 5 were irradiated on both the parotid glands and oropharynx and on the neck from upper to middle through the parallel opposed lateral portals. The radiation dosage ranged from 40 to 44 Gy delivered at 1.8-2.0 Gy per fraction over 4-5 weeks (Table 3) .
CLINICAL COURSE
The patients have been followed for 2-8 years. No relapses have occurred and clinical courses were satisfactory for those in stage I (cases 3-5). After 8 months, a biopsy specimen showed relapse of the inguinal lymph nodes in case I, which was treated with chemotherapy. Since then, he has been alive and well for more than 7 years. It should be noted that this patient did not initially undergo chemotherapy. MRI suggested a tumor relapse in the lymph node of the upper cervical region which had been treated with radiotherapy in case 2. The patient was subjected to additional radiotherapy with 24 Gy of cobalt y-irradiation combined with MACOP-P. Since then, no tumor relapse has been noted at either this or other sites (Table 4) . 
DISCUSSION
It has been reported that 80-85% of parotid gland tumors are benign and 15-20% are malignant (3). It is common knowledge that tumors originating in the parotid gland are without characteristic features in their various imaging presentations and that differentiation between benign and malignant tumors is difficult. However, some workers have reported that these tumors can be differentiated by tumor margins, tumor homogeneity, infiltration into the adjacent tissue and signal intensity in MRI. There are also some correlations between the malignancy seen in histopathological examinations and the fmdings from imaging studies (1, (4) (5) (6) (7) . Malignant lymphoma originating in the parotid gland is relatively rare and occurs in 1-5% of tumors where the parotid gland is the original site of the tumor (2). It is commonly believed that the differentiation of malignant lymphoma originating in the parotid gland from other tumors, including benign tumors, is difficult; however, some authors have reported that malignant lymphomas showed tumor homogeneity surrounded by well defmed margins and were rarely associated with necrosis (8, 9) . The observations of the present cases indicated that it is necessary to consider the possibility of malignant lymphoma even when the lesion rapidly increases in size and exhibits necrosis or an infiltrative tendency in the imaging presentations, strongly suggesting epithelial tumors.
In general, malignant lymphoma originating in the parotid gland is histologically described as low-grade non-Hodgkin's lymphoma, frequently belongs to the B-cell type and rarely relapses into other sites (7, (10) (11) (12) (13) (14) (15) (16) . However, in the present series, two and one of the cases were classified as diffuse large cell type and diffuse small cleaved immunoblastic type, respectively. These three exhibited a tendency to infiltrate the adjacent tissue and tumor inhomogeneity in the imaging findings, suggesting a correlation with a histologically intermediate or high grade of non-Hodgkin's lymphoma. In the present series, it was successfully controlled by radiotherapy, with dosages ranging from 40 to 44 Gy. The patients were followed for 2-8 years and no relapse was found in the three patients with stage 1. However, both stage II patients had relapses and were subjected to additional radiotherapy combined with chemotherapy. Since then, no tumor relapse has been noted at either this or other sites.
Generally, most patients experience xerostomia if a substantial part of the parotid glands is included within the radiation portal. Only one patient (case 1), who received 44 Gy in the bilateral parotid glands, developed mild dry mouth. However, the remaining four patients did not suffer from xerostomia. The low incidence of xerostomia at the time of the last follow-up was thought to be due to the fact that the dosage of less than 44 Gy on the parotid glands did not cause irreversible depression of the parotid function. Franzen et al. (17) reported that most patients who received less than 52 Gy showed a recovery of secretion beginning after 2 months with a continuous improvement of the salivary flow up to 18 months. Also, Valdes Olmos et al. (18) reported that excretion was almost invariably impaired at doses higher than 45 Gy, regardless of the time interval after radiotherapy.
Two patients underwent superficial parotidectomy and and one total parotidectomy. However, more recently, biopsies have been performed in two cases for intraoperative rapid pathological diagnosis (frozen section), as malignant lymphoma was suspected.
In conclusion, malignant lymphoma including intermediate or high grade originating in the parotid gland indicated satisfactory prognosis following radiotherapy and chemotherapy.
